How should I taper off Lexapro (escitalopram)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 3, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

How to Taper Off Lexapro (Escitalopram)

Do not stop Lexapro abruptly—gradual tapering over weeks to months is essential to minimize discontinuation syndrome, which occurs in approximately 50% of patients and can include dizziness, muscle tension, confusion, and emotional symptoms. 1

Key Principles for Tapering

Why Gradual Tapering Matters

  • Discontinuation syndrome is common and predictable: Studies show that higher doses and longer treatment duration increase risk of withdrawal symptoms 2
  • Abrupt discontinuation causes severe symptoms: Dizziness (44%), muscle tension (44%), chills (44%), confusion (40%), amnesia (28%), and emotional lability (28%) are frequently reported 2
  • The FDA label explicitly warns against abrupt discontinuation and mandates discussion of tapering regimens with healthcare providers 1

Tapering Strategy Based on Risk Level

For Standard-Risk Patients (shorter duration of use, lower doses):

  • Reduce dose by 25-50% every 2-4 weeks 3
  • Example: 20 mg → 10 mg (2 weeks) → 5 mg (2 weeks) → stop
  • Monitor closely for withdrawal symptoms at each step

For Higher-Risk Patients (longer duration >1 year, higher doses, previous withdrawal difficulties):

  • Use hyperbolic tapering with much smaller reductions over months 4, 5
  • Reduce by approximately 10% of the current dose per month or slower 3, 5
  • Taper down to very low doses (e.g., 1 mg) before complete cessation 3
  • May require liquid formulations or compounded "mini-doses" for precise small reductions 3, 5

Critical Warning About Alternate-Day Dosing

Never use alternate-day dosing (every other day) as a tapering strategy—this causes severe fluctuations in receptor occupancy and dramatically increases withdrawal symptoms, even at low doses 6. This common practice should be avoided entirely.

Practical Implementation

Monitoring Schedule

  • Follow up every 2-4 weeks during tapering 5
  • Assess for withdrawal symptoms at each visit
  • Be prepared to pause or slow the taper if symptoms emerge 1

Distinguishing Withdrawal from Relapse

Withdrawal symptoms typically:

  • Occur within days of dose reduction
  • Include physical symptoms (dizziness, electric shock sensations, flu-like symptoms)
  • Improve if dose is temporarily increased

Relapse symptoms typically:

  • Develop more gradually (weeks)
  • Match original depression/anxiety symptoms
  • Do not improve with dose restoration

Managing Withdrawal Symptoms

  • If symptoms occur: pause taper or return to previous dose 5
  • Once stabilized, resume tapering at a slower rate
  • Consider extending taper duration to months or even years for difficult cases 5
  • Provide supportive care and reassurance

Special Considerations

Higher-Risk Scenarios Requiring Slower Tapers

  • Treatment duration >1 year 3, 5
  • Doses ≥20 mg 2
  • Previous failed taper attempts 3
  • History of severe withdrawal symptoms 2

Contraindications to Rapid Tapering

  • Pregnancy (risk of withdrawal to fetus) 1
  • Concurrent use of other CNS depressants
  • Active suicidal ideation (requires close monitoring) 1

Common Pitfalls to Avoid

  1. Using alternate-day dosing: This causes receptor occupancy fluctuations and severe withdrawal 6
  2. Tapering too quickly: Standard 2-4 week tapers often fail in long-term users 4, 5
  3. Stopping at minimum therapeutic doses: Taper must continue to sub-therapeutic doses (1-2 mg) 4, 3
  4. Mistaking withdrawal for relapse: Leading to unnecessary resumption of medication 4

Documentation and Patient Education

Inform patients that:

  • Withdrawal symptoms are common but manageable with proper tapering 1
  • The process may take months, not weeks 3, 5
  • Symptoms do not indicate addiction or treatment failure
  • They should report any concerning symptoms immediately 1
  • Very slow tapering (10% monthly reductions) minimizes risk 3, 5

References

Research

Stopping antidepressants: when and how.

Australian prescriber, 2026

Research

Stopping antidepressants safely.

African journal of primary health care & family medicine, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.